209 related articles for article (PubMed ID: 1099016)
1. Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase.
Matsuo E; Skinsnes OK; Chang PH
Int J Lepr Other Mycobact Dis; 1975; 43(1):1-13. PubMed ID: 1099016
[TBL] [Abstract][Full Text] [Related]
2. Acid mucopolysaccharide metabolism in leprosy. 2. Subcellular localization of hyaluronic acid and beta-glucuronidase in leprous infiltrates suggestive of a host-Mycobacterium leprae metabolic relationship.
Matsuo E; Skinsnes OK
Int J Lepr Other Mycobact Dis; 1974; 42(4):399-411. PubMed ID: 4282081
[TBL] [Abstract][Full Text] [Related]
3. Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad.
Hastings RC; Richard V; Christy SA; Morales MJ
Int J Lepr Other Mycobact Dis; 1976; 44(4):427-30. PubMed ID: 798727
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural features of the multiplication of human and murine leprosy bacilli in macrophages of nude mice.
Fukunishi Y; Okada S; Nishiura M; Kohsaka K
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):68-75. PubMed ID: 7042613
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Histochemical analysis of leprous tissue leads to cultivation of leprosy bacilli.
Skinsnes OK
Arch Pathol Lab Med; 1976 Apr; 100(4):173-4. PubMed ID: 786212
[No Abstract] [Full Text] [Related]
6. Acid mucopolysaccharide metabolism in leprosy. 1. Storage of hyaluronic acid and its possible significance in the pathogenesis of leprosy.
Skinsnes OK; Matsuo E
Int J Lepr Other Mycobact Dis; 1974; 42(4):392-8. PubMed ID: 4142476
[TBL] [Abstract][Full Text] [Related]
7. Attempts at growth of M. leprae in mice and observations on a case of probable contamination with another acid-fast bacillus.
Ogawa T
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):27-38. PubMed ID: 776864
[No Abstract] [Full Text] [Related]
8. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
Fieldsteel AH; Levy L
Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
[TBL] [Abstract][Full Text] [Related]
9. Oxidation of 3,4-dihydroxyphenylalanine by connective tissue constituents. Identification of Mycobacterium leprae not related to phenolase activity.
Kato L; Ishaque M; Adapoe C
Int J Lepr Other Mycobact Dis; 1976; 44(4):435-42. PubMed ID: 828625
[TBL] [Abstract][Full Text] [Related]
10. In vitro cultivation of leprosy bacilli in hyaluronic acid-based medium. 2. Progress and developing concept of the role of hyaluronic acid suggested by culture and armadillo infection studies.
Skinsnes OK; Kuba BA; Chang PH; Kuwahara T
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):394-413. PubMed ID: 32143
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid, B-glucuronidase, vitamin C and the immune defect in leprosy.
Skinsnes AK; Matsuo E
Int J Dermatol; 1976 May; 15(4):286-9. PubMed ID: 773848
[No Abstract] [Full Text] [Related]
12. In vitro cultivation of leprosy bacilli on hyaluronic acid based medium. 1. Preliminary report.
Skinsnes OK; Matsuo E; Chang PH; Andersson B
Int J Lepr Other Mycobact Dis; 1975; 43(3):193-203. PubMed ID: 767262
[TBL] [Abstract][Full Text] [Related]
13. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
Gelber RH; Humphres RC; Fieldsteel AH
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
[TBL] [Abstract][Full Text] [Related]
14. Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse.
Guelpa-Lauras CC; Perani EG; Giroir AM; Grosset JH
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):70-7. PubMed ID: 3549940
[TBL] [Abstract][Full Text] [Related]
15. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
17. Primary dapsone-resistant leprosy in San Francisco.
Gelber RH
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
[TBL] [Abstract][Full Text] [Related]
19. Mouse foot pad growth of M. leprae in relation to bacteriological index.
Bhatia VN; Balakrishnan S; Venkataramaniah HN; Harikrishnan S
Lepr India; 1983 Apr; 55(2):247-51. PubMed ID: 6355651
[TBL] [Abstract][Full Text] [Related]
20. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
